Mycobacterium fortuitum group periprosthetic joint infection

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 8, 2006, Pages 737-739

  Saccente, Michael ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AZITHROMYCIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; POLY(METHYL METHACRYLATE); TOBRAMYCIN; VANCOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; DEBRIDEMENT; DELAYED DIAGNOSIS; DEVICE REMOVAL; ELECTIVE SURGERY; ERADICATION THERAPY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; KNEE PAIN; KNEE PROSTHESIS; MYCOBACTERIUM FORTUITUM; NONHUMAN; PROSTHESIS INFECTION; PUS; SYNOVECTOMY; SYNOVITIS; TOTAL KNEE REPLACEMENT;

ADULT; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; JOINT DISEASES; MYCOBACTERIUM FORTUITUM; PROSTHESIS-RELATED INFECTIONS;

EID: 33746649030     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500504133     Document Type: Article

References (13)

1. Booth, JE and Jacobson, JA and Kurrus, TA and Edwards, TW. (1979) Infection of prosthetic arthroplasty by Mycobacterium fortuitum: 2 case reports J Bone Joint Surg, 61, pp. 300-2.
2. Horadam, VW and Smilack, JD and Smith, EC. (1982) Mycobacterium fortuitum infection after total hip replacement South Med J, 75, pp. 244-6.
3. Herold, RC and Lotke, PA and MacGregor, RR. (1987) Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum Clin Orthop, 216, pp. 183-6.
4. Woods, GL. (2000) Susceptibility testing for mycobacteria Clin Infect Dis, 31, pp. 1209-25.
5. Brown-Elliott, BA and Wallace, RJ, Jr.(2005) Infections caused by non-tuberculous mycobacteria. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases6th edn. (pp. 2909-16). Philadelphia: Elsevier Churchill Livingstone.
6. Brown-Elliott, BA and Wallace, RJ, Jr. (2002) Clinical and taxonomic status of pathogenic non-pigmented or late-pigmenting rapidly growing mycobacteria Clin Microbiol Rev, 15, pp. 716-46.
7. Hoffman, PC and Fraser, DW and Robiesek, F and O'Bar, PR and Mauney, CU. (1981) Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex J Infect Dis, 143, pp. 533-42.
8. Kuritsky, JN and Bullen, MG and Broome, CV and Silcox, VA and Good, RC and Wallace, RJ, Jr. (1983) Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex Ann Intern Med, 98, pp. 938-9.
9. Wallace, RJ, Jr and Steele, LC and Labidi, A and Silcox, VA. (1989) Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammoplasty despite case clustering in Texas and other southern coastal states J Infect Dis, 160, pp. 281-8.
10. Nolte, FS and Metchock, B.(1995) Mycobacterium. In Manual of Medical Microbiology6th edn. (pp. 400-37). Washington D.C: ASM Press.
11. Wallace, RJ, Jr and Bedsole, G and Sumter, G and Sanders, CV and Steele, LC and Brown, BA and (1990) Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy Antimicrob Agents Chemother, 34, pp. 65-70.
12. Brown, BA and Wallace, RJ, Jr and Onyi, GO and De Rosas, V and Wallace, RJ III. (1992) Activities of 4 macrolides including clarithromycin against Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium chelonae-like organisms Antimicrob Agents Chemother, 36, pp. 180-4.
13. Wallace, RJ and Glassroth, J and Griffith, DE and Olivier, KN and Cook, JL and Gordin, F. (1997) American Thoracic Society: Diagnosis and treatment of disease caused by non-tuberculous mycobacteria Am J Respir Crit Care Med, 156, pp. S1-25.